piracetam has been researched along with Amyloidosis VI in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernstein, RA | 1 |
| Gibbs, M | 1 |
| Hunt Batjer, H | 1 |
1 other study available for piracetam and Amyloidosis VI
| Article | Year |
|---|---|
Clinical diagnosis and successful treatment of inflammatory cerebral amyloid angiopathy.
Topics: Aged; Anticonvulsants; Apolipoprotein E4; Brain Edema; Cerebral Amyloid Angiopathy, Familial; Diffus | 2011 |